Both AEHR and TER sit at the center of the artificial intelligence infrastructure buildout, yet they occupy very different positions within the semiconductor equipment ecosystem. Aehr Test Systems is a focused, fast-growing supplier of wafer-level and package-level burn-in and test systems, while Teradyne is an established automated test equipment and robotics powerhouse. This stock comparison is relevant for traders and investors seeking to weigh a high-beta, high-growth story against a scaled, diversified market leader. By examining relative performance, growth drivers, and market positioning, readers can better assess which profile aligns with their own risk tolerance and time horizon. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
AEHR, or Aehr Test Systems, designs and sells full-wafer contact and burn-in test systems used to improve the reliability of semiconductors, with particular strength in wafer-level burn-in (WLBI) for AI processors and related chips. In recent weeks the company delivered a standout fiscal quarter, roughly tripling revenue year over year and swinging to a net profit. Bookings exceeded revenue, backlog expanded, and management raised its full-year revenue outlook to around $150 million, citing accelerating demand for its AI semiconductor test and burn-in solutions.
That fundamental momentum has been paired with extreme price volatility. Shares have posted a substantial gain over the trailing 12 months and year to date, yet recent market activity has been sharp, with significant drawdowns followed by large single-day rallies around earnings. Sentiment remains divided: bulls emphasize record bookings and a broadening customer base, while bears point to a steep price-to-sales multiple and a still-early profitability profile that leaves the stock sensitive to shifts in AI capital spending. From what I see, the volatility here is worth monitoring closely.
TER, or Teradyne, is a leading provider of automated test equipment (ATE) used to test semiconductors and electronics, complemented by a robotics segment that includes collaborative and mobile robots for manufacturing and warehousing. Recent results have been strong, with revenue rising roughly 70% year over year as AI-related demand drove more than half of sales. Memory test reached a record level, and the company continues to invest in new products aimed at next-generation AI devices.
Like AEHR, Teradyne's share price has experienced meaningful pullbacks from recent highs, reflecting broader semiconductor-sector volatility and investor debate over the durability of AI spending. However, Teradyne's larger scale, diversified end markets, recurring profitability, and a modest dividend provide a different risk profile. Analysts have highlighted both the breadth of its growth drivers and some margin compression tied to product mix, leaving the stock balanced between continued upside and valuation caution.
The clearest contrast between these two names is scale and maturity. TER is a multi-billion-dollar, consistently profitable enterprise with diversified revenue across semiconductor test, system test, and robotics, giving it multiple growth levers and a steadier earnings base. AEHR is far smaller and more concentrated, with its fortunes tightly linked to wafer-level burn-in adoption by a relatively small group of AI processor customers — a setup that can deliver explosive growth but also pronounced volatility.
On momentum, both stocks have benefited from the same AI infrastructure theme, but their paths differ. AEHR's recent quarter showed accelerating revenue and a turn to profitability, while Teradyne's growth, though large in absolute terms, has shown some quarter-to-quarter moderation alongside mild margin pressure from product mix. On valuation, AEHR trades at a premium price-to-sales multiple that leaves little room for error, whereas Teradyne's more moderate multiple and consistent earnings provide greater downside cushion. Risk factors also diverge: customer concentration and early-stage profitability weigh on AEHR, while Teradyne faces competitive pressure and cyclical exposure across a broader test market. I’m watching this closely for how the relative stability plays out.
Based on observable factors including trend consistency, stability, diversification, and profitability, Tickeron's AI would currently favor TER in this comparison. Teradyne's combination of sustained revenue growth, a record memory test contribution, recurring profitability, and a more diversified business model tends to produce a steadier and more reliable trend profile than AEHR's higher-volatility, higher-valuation growth story. While AEHR offers compelling upside tied to its accelerating burn-in adoption, its concentrated customer base and premium valuation introduce greater variability. This analysis uses probabilistic language rather than definitive claims and is not a substitute for independent research.
In my own research, I often turn to Tickeron’s AI Trading Bots to test systematic approaches across volatile names like these. The platform offers a range of strategies with performance records and covered securities, helping users match bots to their preferred timeframes and risk levels. It is a useful way to compare options without committing capital upfront.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 50-day moving average for AEHR moved below the 200-day moving average on November 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 73 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for AEHR entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Oscillator exited the oversold zone, 26 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 33 of 38 cases over the following month. The odds of a continued upward trend are 87%.
Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 243 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.970) is normal, around the industry mean (5.670). AEHR has a moderately low P/E Ratio (-232.913) as compared to the industry average of (68.795). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment